(Q41362717)

English

Effects of suramin on metastatic ability, proliferation, and production of urokinase-type plasminogen activator and plasminogen activator inhibitor type 2 in human renal cell carcinoma cell line SN12C-PM6.

scientific article published on March 1995

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Effects of suramin on metastatic ability, proliferation, and production of urokinase-type plasminogen activator and plasminogen activator inhibitor type 2 in human renal cell carcinoma cell line SN12C-PM6. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

K Marutsuka

1

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Y Hasui

2

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Y Asada

3

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

S Naito

4

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Y Osada

5

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

A Sumiyoshi

6

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

publication date

1 March 1995

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Clinical & Experimental Metastasis

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

116-122

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Comparative study of plasminogen activator antigens in colonic carcinomas and adenomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of suramin in the treatment of metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent research on the biological activity of suramin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin: a novel antineoplastic agent with multiple potential mechanisms of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory effects of suramin on a human renal cell carcinoma line, causing nephrogenic hepatic dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental animal model for mucopolysaccharidosis: suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin. A potent inhibitor of melanoma heparanase and invasion

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin inhibits laminin- and thrombospondin-mediated melanoma cell adhesion and migration and binding of these adhesive proteins to sulfatide

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of lung and liver tumor colonies in mice pretreated with suramin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding of the urokinase-type plasminogen activator to its cell surface receptor is inhibited by low doses of suramin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relevance of plasminogen activators to neoplastic growth. A review of recent literature.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of suramin on in vitro growth of fresh human tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between urokinase-type plasminogen activator production and the metastatic ability of human rectal cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin interference with transforming growth factor-beta inhibition of human renal cell carcinoma in culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of suramin on complement, blood clotting, fibrinolysis and kinin formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disruption of mitochondrial function by suramin measured by rhodamine 123 retention and oxygen consumption in intact DU145 prostate carcinoma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activators, tissue degradation, and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo selection of human renal cell carcinoma cells with high metastatic potential in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7882614

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00133616

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41362717&oldid=2204497569"